0001824299-20-000002.txt : 20200911
0001824299-20-000002.hdr.sgml : 20200911
20200911151408
ACCESSION NUMBER: 0001824299-20-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200911
DATE AS OF CHANGE: 20200911
EFFECTIVENESS DATE: 20200911
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VIN-16 Neurexis Therapeutics, LLC
CENTRAL INDEX KEY: 0001824299
IRS NUMBER: 844983814
STATE OF INCORPORATION: AR
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-375346
FILM NUMBER: 201170765
BUSINESS ADDRESS:
STREET 1: 535 W RESEARCH CENTER BLVD
STREET 2: SUITE 135
CITY: FAYETTEVILLE
STATE: AR
ZIP: 72701
BUSINESS PHONE: 4795212592
MAIL ADDRESS:
STREET 1: 535 W RESEARCH CENTER BLVD
STREET 2: SUITE 135
CITY: FAYETTEVILLE
STATE: AR
ZIP: 72701
FORMER COMPANY:
FORMER CONFORMED NAME: VIN-16 Neurexis Therapeutics
DATE OF NAME CHANGE: 20200911
D
1
primary_doc.xml
X0708
D
LIVE
0001824299
VIN-16 Neurexis Therapeutics, LLC
535 W RESEARCH CENTER BLVD
SUITE 135
FAYETTEVILLE
AR
ARKANSAS
72701
4795212592
ARKANSAS
VIN-16 Neurexis Therapeutics
Limited Liability Company
true
2020
Robert
Calvin
Goforth
535 W. Research Center Blvd.
Suite 135
Fayetteville
AR
ARKANSAS
72701
Executive Officer
Director
CEO of Manager
Other
Decline to Disclose
- 06b
false
2020-08-31
false
true
false
10000
None
None
None
None
N/A
N/A
Fayetteville
AR
ARKANSAS
72701
AR
ARKANSAS
CT
CONNECTICUT
GA
GEORGIA
TX
TEXAS
false
500000
130000
370000
false
9
0
0
0
false
VIN-16 Neurexis Therapeutics, LLC
Robert Calvin Goforth
Robert Calvin Goforth
CEO of Manager
2020-09-11